Bychkovsky BL, Lin NU (2017) Imaging in the evaluation and follow-up of early and advanced breast cancer: When, why, and how often? Breast 1(31):318–324

Article  Google Scholar 

Hahn EE, Tang T, Lee JS, Munoz-Plaza CE, Shen E, Rowley B et al (2016) Use of posttreatment imaging and biomarkers in survivors of early-stage breast cancer: Inappropriate surveillance or necessary care? Cancer 122(6):908–916

Article  PubMed  Google Scholar 

Kast K, Link T, Friedrich K, Petzold A, Niedostatek A, Schoffer O et al (2015) Impact of breast cancer subtypes and patterns of metastasis on outcome. Breast Cancer Res Treat 150(3):621–629

Article  CAS  PubMed  Google Scholar 

Van Mechelen M, Van Herck A, Punie K, Nevelsteen I, Smeets A, Neven P et al (2020) Behavior of metastatic breast cancer according to subtype. Breast Cancer Res Treat 181(1):115–125

Article  PubMed  Google Scholar 

Wu Q, Li J, Zhu S, Wu J, Chen C, Liu Q et al (2017) Breast cancer subtypes predict the preferential site of distant metastases: A SEER based study. Oncotarget 8(17):27990–27996

Article  PubMed  PubMed Central  Google Scholar 

Veys I (2018) Follow-up of breast cancer patients by general practitioner. Rev Med Brux 39(4):280–286

CAS  PubMed  Google Scholar 

Malmgren J, Hurlbert M, Atwood M, Henry M, Kaplan G, Kaplan HG (2019) Examination of a paradox: recurrent metastatic breast cancer incidence decline without improved distant disease survival 1990–2011. Breast Cancer Res Treat 174(2):505–514

Article  PubMed  Google Scholar 

Ebner F, Wöckel A, Schwentner L, Blettner M, Janni W, Kreienberg R et al (2019) Does the number of removed axillary lymphnodes in high risk breast cancer patients influence the survival? BMC Cancer 19:1. https://doi.org/10.1186/s12885-019-5292-2

Article  Google Scholar 

Schwentner L, Wöckel A, König J, Janni W, Ebner F, Blettner M, et al. Adherence to treatment guidelines and survival in triple-negative breast cancer: a retrospective multi-center cohort study with 9156 patients. 2013. http://www.biomedcentral.com/1471-2407/13/487

Wolters R, Wöckel A, Janni W, Novopashenny I, Ebner F, Kreienberg R et al (2013) Comparing the outcome between multicentric and multifocal breast cancer: What is the impact on survival, and is there a role for guideline-adherent adjuvant therapy? A retrospective multicenter cohort study of 8,935 patients. Breast Cancer Res Treat 142(3):579–590

Article  CAS  PubMed  Google Scholar 

Schouten LJ, Jager JJ, Van Den Brandt PA, Schouten LJ (1993) Quality of cancer registry data: a comparison of data provided by clinicians with those of registration personnel. Br J Cancer 68:1

Article  Google Scholar 

Goldhirsch A, Wood WC, Coates AS, Gelber RD, Thürlimann B, Senn HJ (2011) Strategies for subtypes–dealing with the diversity of breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011. Ann Oncol Off J Eur Soc Med Oncol 22(8):1736–1747

Article  CAS  Google Scholar 

Lips EH, Mulder L, De Ronde JJ, Mandjes IAM, Koolen BB, Wessels LFA et al (2013) Breast cancer subtyping by immunohistochemistry and histological grade outperforms breast cancer intrinsic subtypes in predicting neoadjuvant chemotherapy response. Breast Cancer Res Treat 140(1):63–71

Article  CAS  PubMed  PubMed Central  Google Scholar 

Von Minckwitz G, Untch M, Blohmer JU, Costa SD, Eidtmann H, Fasching PA et al (2012) Definition and impact of pathologic complete response on prognosis after neoadjuvant chemotherapy in various intrinsic breast cancer subtypes. J Clin Oncol 30(15):1796–1804

Article  Google Scholar 

Ehinger A, Malmström P, Bendahl PO, Elston CW, Falck AK, Forsare C et al (2017) Histological grade provides significant prognostic information in addition to breast cancer subtypes defined according to St Gallen 2013. Acta Oncol 56(1):68–74

Article  CAS  PubMed  Google Scholar 

Li J, Chen Z, Su K, Zeng J (2015) Clinicopathological classification and traditional prognostic indicators of breast cancer. Int J Clin Exp Pathol 8(7):8500

PubMed  PubMed Central  Google Scholar 

Wischnewsky M, Schwentner L, Diessner JD, De Gregorio A, Joukhadar R, Davut D et al (2021) BRENDA-Score, a Highly Significant, Internally and Externally Validated Prognostic Marker for Metastatic Recurrence: Analysis of 10,449 Primary Breast Cancer Patients. Cancers (Basel) 13:13

Article  Google Scholar 

Heagerty PJ, Lumley T, Pepe MS (2000) Time-dependent ROC curves for censored survival data and a diagnostic marker. Biometrics 56(2):337–344

Article  CAS  PubMed  Google Scholar 

Leitlinienprogramm Onkologie (Deutsche Krebsgesellschaft, Deutsche Krebshilfe A. S3-Leitlinie Früherkennung, Diagnose, Therapie und Nachsorge des Mammakarzinoms, Leitlinienreport 4.1 https://www.leitlinienprogramm-onkologie.de/leitlinien/mammakarzinom/. 2019 [cited 2020 Oct 20]. p. 1–422. http://www.leitlinienprogramm-onkologie.de/fileadmin/user_upload/Downloads/Leitlinien/Mammakarzinom_4_0/LL_Mammakarzinom_Langversion_Konsultationsfassung_Version_0.4.1.pdf

Chu J, Yang D, Wang L, Xia J (2020) Nomograms predicting survival for all four subtypes of breast cancer: a SEER-based population study. Ann Transl Med 8(8):544–544

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lin M, Jin Y, Jin J, Wang B, Hu X, Zhang J et al (2020) A risk stratification model for predicting brain metastasis and brain screening benefit in patients with metastatic triple-negative breast cancer. Cancer Med 1:1–12

Google Scholar 

Wang Y, Yang Y, Chen Z, Zhu T, Wu J, Su F et al (2019) Development and validation of a novel nomogram for predicting distant metastasis-free survival among breast cancer patients. Ann Transl Med 7(20):537–537

Article  CAS  PubMed  PubMed Central  Google Scholar 

Giess CS, Poole PS, Chikarmane SA, Sippo DA, Birdwell RL (2015) Screening Breast MRI in Patients Previously Treated for Breast Cancer: Diagnostic Yield for Cancer and Abnormal Interpretation Rate. Acad Radiol 22(11):1331–1337

Article  PubMed  Google Scholar 

Kwon M, Ko EY, Han B-K, Ko ES, Choi JS, Park KW (2020) Diagnostic performance of abbreviated breast MRI for screening of women with previously treated breast cancer. Medicine (Baltimore) 99(16):e19676

Article  CAS  PubMed  Google Scholar 

Cheng FT-F, Lapke N, Wu C-C, Lu Y-J, Chen S-J, Yu P-N, et al. Liquid Biopsy Detects Relapse Five Months Earlier than Regular Clinical Follow-Up and Guides Targeted Treatment in Breast Cancer. Case Rep Oncol Med 2019; 2019:1–4

Lin Z, Yan S, Zhang J, Pan Q (2018) A nomogram for distinction and potential prediction of liver metastasis in breast cancer patients. J Cancer 9(12):2098–2106

Article  PubMed  PubMed Central  Google Scholar 

Voelkel V, Draeger T, Groothuis-Oudshoorn CGMM, de Munck L, Hueting T, Gerken M et al (2019) Predicting the risk of locoregional recurrence after early breast cancer: an external validation of the Dutch INFLUENCE-nomogram with clinical cancer registry data from Germany. J Cancer Res Clin Oncol 145(7):1823–1833

Article  PubMed  PubMed Central  Google Scholar 

Zhao YX, Liu YR, Xie S, Jiang YZ, Shao ZM (2019) A nomogram predicting lymph node metastasis in t1 breast cancer based on the surveillance, epidemiology, and end results program. J Cancer 10(11):2443–2449

Article  PubMed  PubMed Central  Google Scholar 

Lin S, Mo H, Li Y, Guan X, Chen Y, Wang Z et al (2020) Development and validation of a nomogram for predicting survival of advanced breast cancer patients in China. Breast 53:172–180. https://doi.org/10.1016/j.breast.2020.08.004

Article  PubMed  PubMed Central  Google Scholar 

Takada M, Sugimoto M, Masuda N, Iwata H, Kuroi K, Yamashiro H et al (2018) Prediction of postoperative disease-free survival and brain metastasis for HER2-positive breast cancer patients treated with neoadjuvant chemotherapy plus trastuzumab using a machine learning algorithm. Breast Cancer Res Treat 172(3):611–618

Article  CAS  PubMed  Google Scholar 

Graesslin O, Abdulkarim BS, Coutant C, Huguet F, Gabos Z, Hsu L et al (2010) Nomogram to predict subsequent brain metastasis in patients with metastatic breast cancer. J Clin Oncol 28(12):2032–2037

Article  PubMed  Google Scholar 

Chu X, Li S, Xia B, Chu L, Yang X, Ni J et al (2019) Patterns of brain metastasis immediately before prophylactic cranial irradiation (PCI): Implications for PCI optimization in limited-stage small cell lung cancer. Radiat Oncol 14:1

Article  Google Scholar 

Yu J, Ouyang W, Yang Y, Zhang X, Zhou Y, Zhang J et al (2020) Prophylactic cranial irradiation for extensive-stage small cell lung cancer: Analysis based on active brain MRI surveillance. Clin Transl Radiat Oncol 25:16–21

Article  PubMed  PubMed Central  Google Scholar 

Delpech Y, Bashour SI, Lousquy R, Rouzier R, Hess K, Coutant C et al (2015) Clinical nomogram to predict bone-only metastasis in patients with early breast carcinoma. Br J Cancer 113(7):1003–1009

Article  CAS  PubMed  PubMed Central  Google Scholar 

Witteveen A, Vliegen IMH, Sonke GS, Klaase JM, IJzerman MJ, Siesling S (2015) Personalisation of breast cancer follow-up: a time-dependent prognostic nomogram for the estimation of annual risk of locoregional recurrence in early breast cancer patients. Breast Cancer Res Treat 152(3):627–636

Article  PubMed  PubMed Central  Google Scholar 

Saltbæk L, Horsboel TA, Offersen BV, Andersson M, Friberg AS, Skriver SK et al (2020) Patterns in detection of recurrence among patients treated for breast cancer. Breast Cancer Res Treat 184(2):365–373

Article  PubMed  Google Scholar 

Ricci-Cabello I, Vásquez-Mejía A, Canelo-AybarC,Niño De Guzman E, Pérez-Bracchiglione J, Rabassa M, et al (2020) Adherence to breast cancer guidelines is associated with better survival outcomes: A systematic review and meta-analysis of observational studies in EU countries. BMC Health Serv Res 20:1

Article  Google Scholar 

Cardoso F, Kyriakides S, Ohno S, Penault-Llorca F, Poortmans P, Rubio IT et al (2019) Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 30(8):1194–1220

Article  CAS  PubMed  Google Scholar 

Høeg BL, Bidstrup PE, Karlsen RV, Friberg AS, Albieri V, Dalton SO et al (2019) Follow-up strategies following completion of primary cancer treatment in adult cancer survivors. Cochrane Database Syst Rev. https://doi.org/10.1002/14651858.CD012425.pub2

Article  PubMed  PubMed Central